Convertibles Calendar: Inotek selling convertible notes

On The Horizon

INOTEK PHARMACEUTICALS CORP.:

• $50 million of convertible senior notes due Aug. 1, 2021

• Price talk 5.5% to 65%, up 15% to 20%

• Cowen & Co. LLC (bookrunner)

• Proceeds will be used to fund continued testing of the company’s trabodenoson drug as a monotherapy and as a fixed-dose combination with latanoprost for the reduction of intraocular pressure. Funds will also be used for general corporate purposes.

• Lexington, Mass.-based biopharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.